You are here: Home » Companies » News
Business Standard

Sebi imposes Rs 22.7 crore fine on Aurobindo Pharma for insider trading

The order said that the penalty amount will be paid within 45 days of receipt of this order

ANI 

Aurobindo Pharma
Aurobindo Pharma

The Securities Exchange Board of India (SEBI) has imposed penalties of Rs 22.7 crore on Aurobindo Pharma, its related entities and promoters for violating insider trading rules with respect to a licensing deal it had entered with in 2009.

The order from on Monday stated that the penalties were imposed under Section 15G and Section 15HB read with Section 15J of the Act.

According to the order, a penalty of Rs 5 crore was imposed on P V Ramprasad Reddy, Rs 2 crore on P Suneeta Rani, Rs 10 lakh on Kambam P Reddy, Rs 6 crore on Trident Chemphar Ltd, Rs 10 lakh on Veritaz Health Care Ltd, Rs 7.5 crore on Top Class Capital Markets Pvt Ltd and Rs 2 crore on Ltd under Section 23E of Securities Contracts (Regulation) Act and Section 15HB of Act.

The order said that the penalty amount will be paid within 45 days of receipt of this order.

.

First Published: Tue, September 24 2019. 10:36 IST
RECOMMENDED FOR YOU